Content related to A Potential Biomarker for Pediatric Acute Liver Failure

A surgeon and Research Director for the Division of Abdominal Organ Transplantation, Dr. Emamaullee is taking a high-tech approach to challenge that status quo.

CHLA researchers use imaging mass cytometry analysis of biopsies to find potential biomarkers that can predict transplant rejection.

Children’s Hospital Los Angeles research study uncovers socioeconomic factors that can impact outcomes of patients with pediatric acute liver failure (PALF).

Receiving a liver transplant means also living with the possibility of rejection. Transplant rejection occurs when the body’s immune system attacks the new organ. This risk is highest in the first

Children’s Hospital Los Angeles researchers develop app to predict if children with acute liver failure will need an urgent liver transplant or can recover on their own.

Four investigators share their research—and how the USC/CHLA facility will help bring novel cell therapies to clinical trials faster.

The ambitions of pediatric researchers are global in scale: Beyond patients at their own hospital, they look to shape national and international standards for pediatric care.

A new study finds that blocking Artemis significantly reduces the proliferation of leukemia cells, without affecting normal cells.

CHLA-led study shows reducing disparities in assigning livers for transplant improved outcomes for patients with pediatric acute liver failure.